Are electronic signatures legally binding in the U.S.?

Yes. Electronic signatures are generally enforceable under the federal ESIGN Act (15 U.S.C. §7001) and state UETA laws adopted by most states; validity requires evidence of intent, consent, attribution, and record retention.

Do I need a BAA for study documents with PHI?

Yes. When protected health information is handled, a Business Associate Agreement is required under HIPAA; include BAA terms and controls for access, breach notification, and permitted uses.

Can consent forms be collected electronically?

Yes if the process meets ESIGN consumer disclosure and consent requirements and documents are reproducible; validate that the signer can access and retain electronic records before proceeding.

Is notarization required for study agreements?

Not typically required for most study agreements, but some institutions or sponsors may request notarization; remote notarization rules vary by state and must be confirmed with the state notary authority.

What if a signed agreement contains an error?

Minor clerical errors are often corrected by an amendment or corrective addendum signed by all parties; material changes generally require a formal amendment and possibly IRB notification.

Who can sign on behalf of a site or sponsor?

Only an authorized representative with delegated signature authority should sign; verify delegation records, institutional signature policies, and corporate resolution where applicable.

Electronic Signature
Templates
Healthcare
Healthcare Study Agreement

Healthcare Study Agreement

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

HEALTHCARE STUDY AGREEMENT

This Healthcare Study Agreement (the Agreement) is entered into between Study Sponsor: and Investigator: . Participant Name: . Study Identifier: . Effective Date:

Purpose and Description of Study

The purpose of the study, anticipated procedures, duration, and objectives are described below. The Participant acknowledges receipt of an explanation of procedures, potential benefits, and risks and understands the experimental nature of the study.

Brief study description

Participant Information

Full legal name

Date of birth:

Gender:

Phone:

Address Emergency contact (name and relation) Emergency contact phone

Insurance Information

Insurer / Provider

Policy number:

Group number:

Subscriber name (if different)

Medical History

Current medications Allergies (including drug allergies) Prior surgeries or hospitalizations Chronic conditions

Procedures, Risks and Benefits

The Participant authorizes the Investigator and study personnel to perform those procedures described in the study protocol. The Participant has been informed of the reasonably foreseeable risks, discomforts, potential side effects, and anticipated benefits. The Participant acknowledges that no specific benefit is guaranteed.

Initial to indicate you received and understood the procedure and risk information

Consent Options and Authorizations

Please indicate consent by checking each box below as applicable. Checking a box indicates informed consent for that item.

I consent to the procedures, examinations, and protocol activities as described.

I authorize collection, use, and analysis of my health information and study data for the purposes of this study, including data aggregation and statistical analysis.

I consent to collection and storage of biological samples (blood, tissue, etc.) for current study procedures.

I consent to de-identified use of my samples and data for future research related to the study aims.

I consent to audio and/or video recording during study visits if applicable.

Confidentiality and HIPAA Authorization

By signing, Participant authorizes the use and disclosure of Protected Health Information (PHI) to the Study Sponsor, Investigator, ethics committees, monitors, and regulatory authorities for purposes related to study conduct, monitoring, audit, and regulatory compliance. Information disclosed may include medical history, test results, and treatment data. Reasonable safeguards will be used to protect confidentiality.

I acknowledge that I have received the Notice of Privacy Practices applicable to this study and that I understand my rights to inspect and copy records as provided by law.

I acknowledge receipt of the Notice of Privacy Practices.

Authorization expiration date (unless earlier revoked): . This authorization remains effective until the stated date or until revoked in writing.

Compensation, Costs, and Injury

Participant will be informed of compensation, travel reimbursement, and whether any study-related costs will be billed to insurance or paid by the Sponsor. If applicable, details are provided in the study budget summary.

In the event of research-related injury, reasonable efforts will be made to provide or arrange necessary medical treatment. Neither the Investigator nor the Sponsor guarantees payment for all treatment or assumes liability beyond that required by applicable law and institutional policy.

Voluntary Participation and Withdrawal

Participation is voluntary. The Participant may withdraw from the study at any time without penalty or loss of benefits to which the Participant is otherwise entitled. Withdrawing will not affect the Participant's access to non-research medical care.

Data Use, Publication, and Ownership

Data collected may be used in aggregate and de-identified form for scientific publications, presentations, and regulatory submissions. Ownership of study data and samples shall remain with the Sponsor and Investigator as described in the protocol.

Participant Certification

By signing below, I certify that: (1) I have read (or had read to me) the information in this Agreement and any accompanying materials; (2) I have had the opportunity to ask questions and they have been answered to my satisfaction; (3) I understand the nature of the study and the potential risks and benefits; and (4) I voluntarily agree to participate and authorize the uses and disclosures described herein.

If signing on behalf of the Participant as a legal guardian or authorized representative, complete the Relationship field in the signature block and provide documentation of authority upon request.

Participant Printed Name:

Signature:

Date:

If signing as legal guardian / authorized representative: Relationship:

If guardian, printed name of guardian:

What a Healthcare Study Agreement Covers

A Healthcare Study Agreement is a formal contract that records responsibilities among a study sponsor, investigator, research site, and any vendors for a clinical or observational study. It specifies protocol reference, enrollment criteria, informed consent procedures, data collection and ownership, privacy safeguards, reporting obligations, compensation, indemnification, and termination conditions. The agreement aligns parties on regulatory compliance requirements, including IRB approvals and applicable privacy rules, and establishes audit and recordkeeping obligations to support inspections and publications.

Why you should document study responsibilities

A clear Healthcare Study Agreement reduces ambiguity between sponsor, site, and vendors, supports IRB and regulatory review, preserves participant protections required by HIPAA and FDA rules, and creates an evidentiary record for audits, adverse event reporting, and publication rights.

Who prepares and signs a Healthcare Study Agreement

Typical parties involved in preparing, reviewing, or signing a Healthcare Study Agreement are listed below.

Study sponsors, their clinical operations and legal teams responsible for protocol financing and compliance
Principal investigators, site study coordinators, and hospital contracting offices who manage enrollment and local oversight
Clinical Research Organizations (CROs), central labs, and vendor partners who provide services under the study

Clear role assignment inside the agreement reduces contracting delays and clarifies responsibility for regulatory records and participant safety.

Core elements to include in the agreement

A professional Healthcare Study Agreement should explicitly allocate responsibilities, protect participant privacy, and define data rights, safety reporting, and termination procedures.

Parties & Definitions

Identify each legal party, site affiliation, and defined terms used throughout the agreement to avoid ambiguity during execution and enforcement.

Scope & Protocol

Reference the study protocol, attach schedules of activities, and describe the clinical procedures, enrollment targets, and milestone deliverables in detail.

Informed Consent

Describe how consent will be obtained, documented, and stored, and who is responsible for investigator/site consent language and translations.

Data Use & Ownership

Specify which party owns source data, derived datasets, publication rights, permitted secondary uses, and data transfer or de-identification rules.

Privacy & Security

Detail HIPAA safeguards, encryption expectations, access control, breach notification steps, and any required Business Associate Agreement (BAA).

Liability & Termination

Allocate indemnity, insurance, and termination rights for safety issues, regulatory noncompliance, or material breach, with dispute resolution provisions.

Step-by-step: preparing and executing the agreement

Follow these sequential steps to prepare, review, and finalize a Healthcare Study Agreement.

01

Draft: Populate parties, protocol reference, and key obligations.
02

Internal Review: Legal, compliance, and finance review for risk allocation.
03

IRB & Approvals: Confirm IRB review status and attach approval documents.
04

Execution: Collect signatures and distribute fully executed copies.

Digital workflow settings for compliant e-execution

Configure a secure signing workflow to capture required attestations and audit trail elements for regulatory compliance.

Field	Configuration
Authentication method	Email link with optional SMS or KBA for higher assurance
Consent capture	Require explicit checkbox and timestamp before signature
HIPAA BAA	Activate BAA and limit document access to authorized users
Retention settings	Automate secure archival and exportable audit trails

Typical eSubmission and signing flow

A compliant e-signing flow reduces friction while preserving evidence of intent, attribution, and retention.

Upload Document: Attach final agreement PDF or DOCX with exhibits.
Place Fields: Add signature, initials, and date fields for each signer.
Authenticate Signers: Use email link, SMS code, or stronger identity checks.
Record Audit Trail: Capture timestamp, IP, and action history automatically.

Security and compliance features to require

Encryption: AES-256 at rest; TLS 1.2/1.3 in transit

Audit Trail: Tamper-evident timestamps and event logs

HIPAA BAA: BAA required when PHI is handled

Access Controls: Role-based permissions and SSO options

21 CFR Part 11: Support for FDA-regulated records where needed

Authentication: Multi-factor and identity-proofing options

Key risks and potential consequences

HIPAA Breach: Civil and civil monetary fines

Invalid Consent: Study data may be unusable

Regulatory Delays: Enrollment or approval pauses

Funding Risk: Sponsor may withhold payments

Data Integrity: Questioned results and reanalysis

Contract Disputes: Potential litigation and costs

Time-sensitive actions and typical deadlines

Track these common deadlines to avoid noncompliance and administrative penalties.

IRB Approval Before Enrollment:

Obtain IRB approval under 45 C.F.R. Part 46 prior to starting participant procedures.

Informed Consent Timing:

Consent must be obtained and documented before any study-specific interventions.

Serious Adverse Event Reporting:

Report SAEs to sponsor/IRB and FDA per 21 C.F.R. §312.32 timelines.

Annual Continuing Review:

Complete IRB continuing review or exemption confirmation as institutional policy requires.

Data Retention Start:

Retention obligations begin on effective date or creation of the record.

Key milestones from contract to closeout

Track these major milestones to coordinate contracting, enrollment, and data lock activities.

01

Protocol Finalization

Complete protocol and attach to the agreement before executing contracts.

02

Contract Execution

All parties sign and date the agreement to trigger obligations.

03

Enrollment Start

Begin participant enrollment only after IRB and contract prerequisites are met.

04

Database Lock

Complete data cleaning and lock database prior to primary analysis.

eSignature vendor pricing and feature snapshot

Compare starting prices and key capabilities for commonly used eSignature platforms; signNow is listed first for reference.

	signNow	DocuSign	Adobe Sign	PandaDoc	HelloSign
Starting Price	$8/user/mo	$15/user/mo	$14/user/mo	$19/user/mo	$15/user/mo
Free Trial	7-day free trial	Varies by plan	Varies by plan	Varies by plan	Varies by plan
Bulk Send	Yes (Business Premium)	Yes	Yes	Yes	No
Audit Trail	Yes	Yes	Yes	Yes	Yes
HIPAA Compliant	Yes	Yes	Yes	No	No
Envelope Cap	No envelope cap	100 envelopes/user/year limit	Varies by plan	Varies by plan	Varies by plan

Frequently asked questions about execution and compliance

Answers to common questions about electronic signing, HIPAA, notarization, and what to do if an agreement needs correction.

Need help? Contact support

Are electronic signatures legally binding in the U.S.?
Yes. Electronic signatures are generally enforceable under the federal ESIGN Act (15 U.S.C. §7001) and state UETA laws adopted by most states; validity requires evidence of intent, consent, attribution, and record retention.
Do I need a BAA for study documents with PHI?
Yes. When protected health information is handled, a Business Associate Agreement is required under HIPAA; include BAA terms and controls for access, breach notification, and permitted uses.
Can consent forms be collected electronically?
Yes if the process meets ESIGN consumer disclosure and consent requirements and documents are reproducible; validate that the signer can access and retain electronic records before proceeding.
Is notarization required for study agreements?
Not typically required for most study agreements, but some institutions or sponsors may request notarization; remote notarization rules vary by state and must be confirmed with the state notary authority.
What if a signed agreement contains an error?
Minor clerical errors are often corrected by an amendment or corrective addendum signed by all parties; material changes generally require a formal amendment and possibly IRB notification.
Who can sign on behalf of a site or sponsor?
Only an authorized representative with delegated signature authority should sign; verify delegation records, institutional signature policies, and corporate resolution where applicable.

be ready to get more

Join over 28 million airSlate SignNow users

Sign Now